Idiotypic immunization induces immunity to mutated p53 and tumor rejection

Nature Medicine

Volumn 4, Issue 6, 1998, Pages 710-712

  Ruiz, Pedro J ^a,b   Wolkowicz, Roland ^b   Waisman, Ari ^b   Hirschberg, David L ^a   Carmi, Pnina ^b   Erez, Netta ^b   Garren, Hideki ^a   Herkel, Johannes ^b   Karpuj, Marcela ^b   Steinman, Lawrence ^a,b   Rotter, Varda ^b   Cohen, Irun R ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

IDIOTYPIC ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; MONOCLONAL ANTIBODY; PROTEIN P53;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CANCER IMMUNIZATION; CONTROLLED STUDY; FEMALE; GENE MUTATION; INTRADERMAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SARCOMA; SUBCUTANEOUS DRUG ADMINISTRATION; TUMOR REJECTION;

ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, MONOCLONAL; ANTIBODY FORMATION; EPITOPES; FEMALE; GRAFT REJECTION; IMMUNITY; IMMUNOGLOBULIN LIGHT CHAINS; IMMUNOGLOBULIN VARIABLE REGION; MICE; MICE, INBRED BALB C; MUTATION; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; OLIGOPEPTIDES; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; VACCINATION;

ANIMALIA;

EID: 0031801808     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0698-710     Document Type: Article

References (19)

1. Hollstein, M., Sidransky, D., Vogelstein, B. & Harris, C.C. p53 mutations in human cancers. Science 253, 49-53 (1991).
2. Levine, A. p53, the cellular gatekeeper for growth and division. Cell 88, 323-331 (1997).
3. Bertholet, S., Iggo, R. & Corradin, G. Cytotoxic T lymphocyte responses to wild type and mutant mouse p53 peptides. Eur. J. Immunol. 27, 798-801 (1997).
4. Vierboom, M.P.M. et al. Tumor eradication by wild-type p53-specific cytotoxic T lymphocytes. J. Exp. Med. 186, 695-704 (1997).
5. Nisonoff, A. Idiotypes: concepts and applications. J. Immunol. 147, 2429-2438 (1991).
6. Bona, C.A. Internal image concept revisited. Proc. Soc. Exp. Biol. Med. 213, 32-40 (1996).
7. Fields, B. et al. Molecular basis of antigen mimicry by an anti-idiotype. Nature 374, 739-742 (1995).
8. Nepom, G. et al. Identification of a hemaglutinin-specific idiotype assoicated with reovirus recognition shared by lymphoid and neural cells. J. Exp. Med. 11, 155-167 (1982).
9. Nepom, G. et al. Virus-binding receptors: similarities to immune receptors as determined by anti-idotypic antboides. Surv. Immunol. Res. 1, 255-261, 1982.
10. Eliyahu, D. et al. Meth A fibrosarcoma cells express two transforming mutant p53 species. Oncogene 3, 313-321 (1988).
11. Wucherpfenning, K.W. & Strominger, J.L. Molecular mimicry in T cell mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein. Cell 80, 695-705 (1995).
12. Coffman, R. et al. The role of helper T cell products in mouse B cell differentiation and isotype regulation. Immunol. Rev. 102, 5-28 (1988).
13. Cohen, I. The cognitive paradigm and the immunological homunculus. Immunol. Today 13, 490-494 (1992).
14. Wolkowicz, R., Elkind, N.B., Ronen, D. & Rotter, V. The DNA binding activity of wild type p3 is modulated by blocking its various antigenic epitopes. Oncogene 10, 1167-1174 (1995).
15. Gannon, J.V., Greaves, R., Iggo, R. & Lane, D.P. Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form. Embo J. 9, 1595-1602 (1990).
16. Munro, S. & Pelham, H.R. An Hsp70-like protein in the ER: identity with the 78 kd glucose-regulated protein and immunoglobulin heavy chain binding protein. Cell 46, 291-300 (1986).
17. Orlandi, R., Gussow, D.H., Jones, P.T. & Winter, G. Cloning immunoglobulin variable domains for expression by the polymerase chain reaction. Proc. Natl. Acad. Sci. USA 86, 3833-3837 (1989).
18. Arai, N. et al. Immunologically distinct p53 molecules generated by alternative splicing. Mol Cell Biol 6, 3232-3239 (1986).
19. Coligan, J.E., Kruisbeek, A.M., Margulies, D.H., Shevach, E.M. & Strober, W. Current Protocols in Immunology (John Wiley & Sons, Inc., New York, 1994).